1. Home
  2. XENE vs CPK Comparison

XENE vs CPK Comparison

Compare XENE & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • CPK
  • Stock Information
  • Founded
  • XENE 1996
  • CPK 1990
  • Country
  • XENE Canada
  • CPK United States
  • Employees
  • XENE N/A
  • CPK N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • CPK Oil & Gas Production
  • Sector
  • XENE Health Care
  • CPK Utilities
  • Exchange
  • XENE Nasdaq
  • CPK Nasdaq
  • Market Cap
  • XENE 3.3B
  • CPK 2.9B
  • IPO Year
  • XENE 2014
  • CPK N/A
  • Fundamental
  • Price
  • XENE $41.28
  • CPK $124.50
  • Analyst Decision
  • XENE Strong Buy
  • CPK Hold
  • Analyst Count
  • XENE 9
  • CPK 4
  • Target Price
  • XENE $56.67
  • CPK $123.00
  • AVG Volume (30 Days)
  • XENE 361.3K
  • CPK 93.0K
  • Earning Date
  • XENE 11-12-2024
  • CPK 11-07-2024
  • Dividend Yield
  • XENE N/A
  • CPK 2.00%
  • EPS Growth
  • XENE N/A
  • CPK N/A
  • EPS
  • XENE N/A
  • CPK 4.91
  • Revenue
  • XENE N/A
  • CPK $757,489,000.00
  • Revenue This Year
  • XENE N/A
  • CPK $22.71
  • Revenue Next Year
  • XENE $1,599.99
  • CPK $6.95
  • P/E Ratio
  • XENE N/A
  • CPK $25.69
  • Revenue Growth
  • XENE N/A
  • CPK 12.63
  • 52 Week Low
  • XENE $35.53
  • CPK $98.25
  • 52 Week High
  • XENE $50.99
  • CPK $134.20
  • Technical
  • Relative Strength Index (RSI)
  • XENE 48.67
  • CPK 40.32
  • Support Level
  • XENE $38.95
  • CPK $125.00
  • Resistance Level
  • XENE $43.20
  • CPK $131.11
  • Average True Range (ATR)
  • XENE 1.51
  • CPK 2.40
  • MACD
  • XENE -0.11
  • CPK -0.89
  • Stochastic Oscillator
  • XENE 51.27
  • CPK 8.01

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by their respective PSC. Eastern Shore, its natural gas transmission subsidiary, is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

Share on Social Networks: